Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E-ying Peng
Observed names:
E Peng,
E.-ying Peng,
Eric Y. Peng
Institution:
Guangzhou Medical University
Observed institutions:
Fujian Medical University,
San Francisco VA Medical Center,
University of California, San Francisco,
Sichuan University,
West China Hospital of Sichuan University,
State Key Laboratory of Biotherapy,
Guangzhou Medical University
show all 7
ORCID:
0009-0008-2067-1510
Observed ORCID:
0009-0008-2067-1510
OpenAlex ID:
A5087634565
Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer
2002
·
G Deng
, E Peng
, et al.
·
British Journal of Cancer
·
100
PDF
Presence and diagnostic value of circulating tsncRNA for ovarian tumor
2018
·
Eric Y. Peng
, Yang Shu
, et al.
·
Molecular Cancer
·
23
PDF
METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy
2024
·
Xuefen Zhuang
, Shusha Yin
, et al.
·
Pharmacological Research
·
18
The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer
2024
·
Hongbiao Huang
, Xuefen Zhuang
, et al.
·
Oncogene
·
9
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression
2025
·
Hongbiao Huang
, Yujie Xiang
, et al.
·
Oncogene
·
3
The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer
2026
·
Yuning Liao
, Shusha Yin
, et al.
·
Cancer Letters
·
1
The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1
2026
·
Yuning Liao
, Wenshuang Sun
, et al.
·
Oncogene
Relationship between esophageal cancer and interactions of genes and environmental factors
2004
·
E Peng
Show more works
View as search
Works count:
8
Citation count:
154
H-index:
4
I10-index:
3
Year
Topic
Type
